TRVI Trevi Therapeutics, Inc. - Common Stock
$18,83
Kurs · Aug 19, 2026
Fundamentaldaten per Aug 6, 2026
52W-Spanne
$7–$20
90% of range
Analystenbewertung
BUY
18 analysts
Kursziel
$28
+50% upside
P/E (TTM)
-58.8
ROE
-22.4%
Nettogewinnmarge
—
TRVI Aktien-Snapshot Kurs, Marktkapitalisierung, P/E, EPS, ROE, Schulden/Eigenkapital, 52-Wochen-Spanne
Kurs
$18.83
Marktkapitalisierung
$2.42B
P/E (TTM)
-58.8
EPS (TTM)
$-0.32
Umsatz (TTM)
—
Dividendenrendite
—
ROE
-22.4%
Verschuldungsgrad
—
52W-Spanne
$7 – $20
TRVI Aktienkurs-Chart Täglich OHLCV mit technischen Indikatoren — Schwenken, Zoom und Ansicht anpassen
Configure
10-Jahres-Performance Umsatz-, Nettoergebnis-, Margen- und EPS-Trends
Umsatz & Nettoergebnis
—
EPS
$-0.32
2021-12-31
→
2025-12-31
Freier Cashflow
$-42M
2019-12-31
→
2025-12-31
Margen
—
Bewertung P/E-, P/S-, P/B-, EV/EBITDA-Verhältnisse — ist die Aktie teuer oder günstig?
Kennzahl
5-Jahres-Trend
TRVI
Peer-Median
P/E (TTM)
-58.8
29.4
P/B (K/B)
13.2
6.5
Price / FCF (Kurs / FCF)
-57.4
—
Rentabilität Brutto-, Betriebs- und Nettomargen; ROE, ROA, ROIC
Kennzahl
5-Jahres-Trend
TRVI
Peer-Median
ROA
-28.1%
-8.2%
ROE
-22.4%
-19.4%
ROIC
-26.9%
—
Finanzielle Gesundheit Verschuldung, Liquidität, Solvenz — Bilanzstärke
Kennzahl
5-Jahres-Trend
TRVI
Peer-Median
Current Ratio (Liquiditätsgrad)
19.7
3.6
Quick Ratio
19.3
—
Wachstum Umsatz-, EPS- und Nettoergebniswachstum: YoY, 3-Jahres-CAGR, 5-Jahres-CAGR
Kennzahl
5-Jahres-Trend
TRVI
Peer-Median
Kapitaleffizienz Umsatz pro Vermögenswert, Lagerumschlag, Forderungsumschlag
Kennzahl
5-Jahres-Trend
TRVI
Peer-Median
TRVI Analysten-Konsens Bullische und bärische Analystenmeinungen, 12-Monats-Kursziel, Aufwärtspotenzial
KAUF
18 Analysten
- Starker Kauf 6 33,3%
- Kauf 11 61,1%
- Halten 1 5,6%
- Verkauf 0 0,0%
- Starker Verkauf 0 0,0%
12-Monats-Kursziel
11 Analysten · 2026-08-16
Median
$25.00
Mittelwert
$28.18
← Unter allen Zielen
$18.83
Tief
$23.00
Hoch
$40.00
Median-Ziel
$25.00
+32,8%
Mittelwert-Ziel
$28.18
+49,7%
Ergebnisverlauf EPS Ist vs. Schätzung, Überraschung %, Beat-Rate, nächstes Ergebnisdatum
Durchschn. Überraschung
0.02%
| Zeitraum | EPS Actual | EPS est. | Überraschung |
|---|---|---|---|
| 30. Juni 2026 | $-0.11 | $-0.11 | 0.00% |
| 31. März 2026 | $-0.09 | $-0.08 | -0.01% |
| 31. Dezember 2025 | $-0.06 | $-0.10 | 0.04% |
| 30. September 2025 | $-0.08 | $-0.10 | 0.02% |
| 30. Juni 2025 | $-0.09 | $-0.10 | 0.01% |
| 31. März 2025 | $-0.09 | $-0.12 | 0.03% |
| 31. Dezember 2024 | $-0.11 | $-0.12 | 0.01% |
Peer-Vergleich (GICS-Subbranche) Wichtige Kennzahlen im Vergleich zu Branchenkollegen
| Ticker | Marktkapitalisierung | P/E | Umsatz Vj. | Nettomarge | ROE | Bruttogewinnmarge |
|---|---|---|---|---|---|---|
| TRVI | $1.61B | -39.1 | — | — | -22.4% | — |
| MBX | $1.42B | -13.3 | — | — | -29.6% | — |
| TARS | $3.48B | -51.5 | 146.7% | -14.7% | -19.7% | — |
| ALMS | — | -3.4 | — | -1011.8% | -61.9% | — |
| SUPN | $2.86B | -73.1 | 8.6% | -5.4% | -3.6% | — |
| ATAI | $223M | -1.4 | -1.9% | -48464.0% | -83.1% | — |
| NUVB | $3.03B | -14.9 | 699.0% | -325.3% | -60.3% | — |
| NKTR | $862M | -4.3 | -43.9% | -297.1% | -500.1% | — |
| OCUL | $2.62B | -8.5 | -18.5% | -511.9% | -55.4% | — |
| PBH | $3.33B | 15.2 | -4.3% | 17.5% | 10.2% | 54.7% |
| AMRX | — | 57.3 | 8.1% | 2.4% | -80.0% | 36.9% |
Vollständige Fundamentaldaten Alle Kennzahlen nach Jahr — Gewinn- und Verlustrechnung, Bilanz, Cashflow
Gewinn- und Verlustrechnung 15
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| R&D Expense | $33M | $39M | $24M | $20M | $23M | $22M | $19M | $14M | |
| SG&A Expense | $16M | $12M | $10M | $10M | $9M | $10M | $7M | $4M | |
| Operating Expenses | $49M | $52M | $34M | $30M | $32M | $32M | $27M | $18M | |
| Operating Income | $-49M | $-52M | $-34M | $-30M | $-32M | $-32M | $-27M | $-18M | |
| Interest Expense | · | · | $391.0K | $1M | $1M | $456.0K | · | $174.0K | |
| Interest Income | $7M | $4M | $5M | · | · | · | · | · | |
| Other Non-op | $-31.0K | $-15.0K | $469.0K | $289.0K | $-375.0K | $-287.0K | $577.0K | $-2M | |
| Pretax Income | $-43M | $-48M | $-29M | $-29M | $-34M | $-33M | $-26M | $-21M | |
| Income Tax | $-64.0K | $-30.0K | $-32.0K | $-36.0K | $-21.0K | $-18.0K | $-18.0K | $-124.0K | |
| Net Income | $-43M | $-48M | $-29M | $-29M | $-34M | $-33M | $-26M | $-21M | |
| EPS (Basic) | $-0.32 | $-0.47 | $-0.29 | $-0.45 | $-1.49 | · | · | · | |
| EPS (Diluted) | $-0.32 | $-0.47 | $-0.29 | $-0.45 | $-1.49 | · | · | · | |
| Shares (Basic) | 134,747,198 | 101,971,873 | 99,033,373 | 64,541,911 | 22,841,481 | · | · | · | |
| Shares (Diluted) | 134,747,198 | 101,971,873 | 99,033,373 | 64,541,911 | 22,841,481 | · | · | · | |
| EBITDA | $-49M | $-51M | $-34M | $-30M | $-32M | $-32M | $-27M | · |
Bilanz 23
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $19M | $34M | $32M | $13M | $37M | $45M | $57M | $7M | |
| Short-term Investments | $169M | $74M | $51M | $108M | · | · | · | · | |
| Prepaid Expense | $1M | $939.0K | $4M | $795.0K | $886.0K | $1M | $2M | $1M | |
| Other Current Assets | $2M | $867.0K | $955.0K | $1M | $241.0K | $265.0K | · | · | |
| Current Assets | $192M | $109M | $88M | $123M | $38M | $46M | $60M | $9M | |
| PP&E (Net) | $178.0K | $157.0K | $216.0K | $170.0K | $53.0K | $103.0K | $118.0K | $149.0K | |
| PP&E (Gross) | $537.0K | $385.0K | $350.0K | $395.0K | $235.0K | $235.0K | $203.0K | $195.0K | |
| Accum. Depreciation | $359.0K | $228.0K | $134.0K | $225.0K | $182.0K | $132.0K | $85.0K | $46.0K | |
| Other Non-current Assets | $928.0K | $243.0K | $297.0K | $205.0K | $334.0K | $532.0K | · | · | |
| Total Assets | $193M | $111M | $89M | $123M | $38M | $47M | $60M | $11M | |
| Accounts Payable | $4M | $3M | $2M | $3M | $3M | $2M | $2M | $603.0K | |
| Accrued Liabilities | $6M | $7M | $4M | $4M | $4M | $3M | $4M | $2M | |
| Current Liabilities | $10M | $11M | $6M | $13M | $13M | $6M | $5M | $3M | |
| Capital Leases | $446.0K | $747.0K | $1M | $2.0K | $24.0K | $144.0K | $257.0K | $46.0K | |
| Other Non-current Liabilities | · | · | · | $3.0K | · | · | · | · | |
| Total Liabilities | $10M | $11M | $7M | $16M | $21M | $20M | · | · | |
| Common Stock | $128.0K | $94.0K | $68.0K | $60.0K | $29.0K | $19.0K | $18.0K | $4.0K | |
| Paid-in Capital | $513M | $387M | $322M | $318M | $198M | $174M | $169M | · | |
| Retained Earnings | $-330M | $-287M | $-239M | $-210M | $-181M | $-147M | $-114M | $-109M | |
| AOCI | $148.0K | $61.0K | $-29.0K | $-122.0K | · | · | · | · | |
| Stockholders' Equity | $183M | $100M | $83M | $107M | $17M | $27M | $55M | $-109M | |
| Liabilities + Equity | $193M | $111M | $89M | $123M | $38M | $47M | $60M | $11M | |
| Shares Outstanding | 128,306,056 | 93,602,631 | 68,283,699 | 59,943,430 | 28,505,804 | 18,546,786 | 17,834,570 | 438,600 |
Cashflow 13
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| D&A | $144.0K | $147.0K | $123.0K | $43.0K | · | · | · | · | |
| Stock-based Comp | $5M | $4M | $2M | $2M | $3M | $2M | $1M | $496.0K | |
| Other Non-cash | $-5M | $6M | $-5M | · | · | · | · | · | |
| Operating Cash Flow | $-42M | $-38M | $-32M | $-28M | $-29M | $-29M | $-23M | $-18M | |
| CapEx | $12.0K | $35.0K | $137.0K | $159.0K | · | $32.0K | $9.0K | $158.0K | |
| Investing Cash Flow | $-94M | $-22M | $59M | $-107M | · | $-32.0K | $-9.0K | $-158.0K | |
| Debt Issued | · | · | · | · | · | $14M | · | · | |
| Net Debt Issued | · | · | · | $-6M | · | $14M | · | · | |
| Financing Cash Flow | $121M | $61M | $-8M | $111M | $21M | $17M | $73M | $4M | |
| Net Change in Cash | $-15M | $2M | $20M | $-24M | $-8M | $-12M | $50M | $-15M | |
| Taxes Paid | $-33.0K | $-32.0K | · | · | · | · | · | · | |
| Free Cash Flow | $-42M | $-38M | $-32M | $-28M | · | $-29M | $-23M | · | |
| Levered FCF | · | · | $-32M | $-29M | · | $-29M | · | · |
Rentabilität 3
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| ROA | -28.1% | -47.8% | -27.4% | -36.1% | -79.3% | -61.2% | -73.9% | · | |
| ROE | -22.4% | -60.4% | -33.8% | -26.8% | -238.5% | -104.2% | -45.2% | · | |
| ROIC | -26.9% | -51.7% | -41.0% | -27.8% | -190.1% | -119.0% | -48.8% | · |
Liquidität & Solvenz 3
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 19.7 | 10.4 | 15.0 | 9.2 | 3.0 | 8.3 | 11.5 | · | |
| Quick Ratio | 19.3 | 10.2 | 14.2 | 9.0 | 2.9 | 8.1 | 11.0 | · | |
| Interest Coverage | · | · | -86.8 | -25.7 | -27.0 | -71.2 | · | · |
Bewertung (TTM) 8
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Net Income TTM | $-43M | $-48M | $-29M | $-29M | $-34M | $-33M | $-26M | · | |
| Market Cap | $1.61B | $386M | $92M | $116M | $22M | $45M | $67M | · | |
| P/E | -39.1 | -8.8 | -4.6 | -4.3 | -0.5 | · | · | · | |
| P/B | 8.8 | 3.9 | 1.1 | 1.1 | 1.3 | 1.6 | 1.2 | · | |
| P / Tangible Book | 8.8 | 3.9 | 1.1 | 1.1 | 1.3 | 1.6 | · | · | |
| P / Cash Flow | -38.2 | -10.1 | -2.9 | -4.1 | -0.8 | -1.5 | -2.9 | · | |
| P / FCF | -38.2 | -10.1 | -2.9 | -4.1 | · | -1.5 | -2.9 | · | |
| Earnings Yield | -2.6% | -11.4% | -21.6% | -23.3% | -190.5% | · | · | · |
Gewinn- und Verlustrechnung 15
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| R&D Expense | $15M | $10M | $6M | $10M | $9M | $8M | $9M | $11M | $10M | $9M | $7M | $6M | $6M | $5M | $4M | $6M | |
| SG&A Expense | $5M | $5M | $4M | $4M | $4M | $4M | $3M | $3M | $3M | $3M | $2M | $3M | $3M | $3M | $2M | $3M | |
| Operating Expenses | $21M | $15M | $10M | $14M | $14M | $11M | $12M | $14M | $13M | $12M | $9M | $9M | $8M | $8M | $7M | $8M | |
| Operating Income | $-21M | $-15M | $-10M | $-14M | $-14M | $-11M | $-12M | $-14M | $-13M | $-12M | $-9M | $-9M | $-8M | $-8M | $-7M | $-8M | |
| Interest Expense | · | · | · | · | · | · | · | · | $1.0K | $1.0K | · | $3.0K | $153.0K | $231.0K | $274.0K | $292.0K | |
| Interest Income | $3M | $2M | $2M | $2M | $1M | $1M | $843.0K | $826.0K | $935.0K | $998.0K | $1M | $1M | · | · | · | · | |
| Other Non-op | $-3.0K | $4.0K | $-16.0K | $-2.0K | $-7.0K | $-6.0K | $2.0K | $-11.0K | $-5.0K | $-1.0K | $-3.0K | $154.0K | $153.0K | $165.0K | $702.0K | $132.0K | |
| Pretax Income | $-18M | $-13M | $-8M | $-12M | $-12M | $-10M | $-11M | $-13M | $-12M | $-11M | $-8M | $-8M | $-7M | $-6M | $-6M | $-8M | |
| Income Tax | $-19.0K | $-20.0K | $-17.0K | $-15.0K | $-21.0K | $-11.0K | $17.0K | $-31.0K | $-8.0K | $-8.0K | $18.0K | $-13.0K | $-30.0K | $-7.0K | $-20.0K | $-7.0K | |
| Net Income | $-18M | $-13M | $-8M | $-12M | $-12M | $-10M | $-11M | $-13M | $-12M | $-11M | $-8M | $-8M | $-7M | $-6M | $-6M | $-8M | |
| EPS (Basic) | $-0.11 | $-0.09 | $-0.06 | $-0.08 | $-0.09 | $-0.09 | $-0.11 | $-0.13 | $-0.12 | $-0.11 | $-0.08 | $-0.08 | $-0.07 | $-0.06 | $0.05 | $-0.12 | |
| EPS (Diluted) | $-0.11 | $-0.09 | $-0.06 | $-0.08 | $-0.09 | $-0.09 | $-0.11 | $-0.13 | $-0.12 | $-0.11 | $-0.08 | $-0.08 | $-0.07 | $-0.06 | $0.05 | $-0.12 | |
| Shares (Basic) | 156,602,158 | 145,592,901 | -258,318,929 | 145,104,986 | 130,350,391 | 117,610,750 | -199,869,140 | 101,282,228 | 101,041,573 | 99,517,212 | -197,601,417 | 99,325,540 | 98,698,579 | 98,610,671 | -94,705,331 | 68,898,810 | |
| Shares (Diluted) | 156,602,158 | 145,592,901 | -258,318,929 | 145,104,986 | 130,350,391 | 117,610,750 | -199,869,140 | 101,282,228 | 101,041,573 | 99,517,212 | -197,601,417 | 99,325,540 | 98,698,579 | 98,610,671 | -94,705,331 | 68,898,810 | |
| EBITDA | $-21M | $-15M | · | $-14M | $-14M | $-11M | · | $-14M | $-13M | $-12M | · | $-9M | $-8M | $-8M | · | $-8M |
Bilanz 23
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $54M | $19M | $19M | $57M | $117M | $19M | $34M | $16M | $13M | $14M | $32M | $26M | $14M | $12M | $13M | $67M | |
| Short-term Investments | $265M | $152M | $169M | $138M | $87M | $84M | $74M | $49M | $57M | $59M | $51M | $63M | $80M | $100M | $108M | $59M | |
| Prepaid Expense | $4M | $2M | $1M | $1M | $2M | $2M | $939.0K | $1M | $2M | $3M | $4M | $4M | $3M | $1M | $795.0K | $1M | |
| Other Current Assets | $3M | $2M | $2M | $2M | $2M | $834.0K | $867.0K | $667.0K | $830.0K | $721.0K | $955.0K | $1M | $2M | $2M | $1M | $421.0K | |
| Current Assets | $326M | $176M | $192M | $198M | $207M | $106M | $109M | $67M | $72M | $77M | $88M | $94M | $99M | $114M | $123M | $127M | |
| PP&E (Net) | $336.0K | $265.0K | $178.0K | $213.0K | $239.0K | $277.0K | $157.0K | $174.0K | $198.0K | $204.0K | $216.0K | $238.0K | $225.0K | $245.0K | $170.0K | $68.0K | |
| PP&E (Gross) | · | · | $537.0K | · | · | · | $385.0K | · | · | · | $350.0K | · | · | · | $395.0K | · | |
| Accum. Depreciation | · | · | $359.0K | · | · | · | $228.0K | · | · | · | $134.0K | · | · | · | $225.0K | · | |
| Other Non-current Assets | $4M | $3M | $928.0K | $103.0K | $68.0K | $241.0K | $243.0K | $256.0K | $273.0K | $311.0K | $297.0K | $297.0K | $68.0K | $225.0K | $205.0K | $922.0K | |
| Total Assets | $331M | $180M | $193M | $199M | $208M | $107M | $111M | $69M | $74M | $79M | $89M | $96M | $101M | $116M | $123M | $128M | |
| Accounts Payable | $3M | $2M | $4M | $3M | $3M | $1M | $3M | $2M | $2M | $2M | $2M | $1M | $1M | $2M | $3M | $2M | |
| Accrued Liabilities | $5M | $5M | $6M | $6M | $6M | $5M | $7M | $7M | $5M | $3M | $4M | $4M | $3M | $3M | $4M | $5M | |
| Current Liabilities | $9M | $7M | $10M | $9M | $9M | $7M | $11M | $9M | $7M | $5M | $6M | $5M | $5M | $13M | $13M | $15M | |
| Capital Leases | $276.0K | $364.0K | $446.0K | $527.0K | $605.0K | $681.0K | $747.0K | $816.0K | $884.0K | $949.0K | $1M | $1M | $1M | $1M | $2.0K | $2.0K | |
| Other Non-current Liabilities | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $3.0K | $15.0K | |
| Total Liabilities | $9M | $7M | $10M | $10M | $10M | $8M | $11M | $10M | $8M | $6M | $7M | $6M | $6M | $14M | $16M | $18M | |
| Common Stock | $142.0K | $128.0K | $128.0K | $128.0K | $122.0K | $100.0K | $94.0K | $75.0K | $73.0K | $69.0K | $68.0K | $64.0K | $63.0K | $60.0K | $60.0K | $58.0K | |
| Paid-in Capital | $683M | $515M | $513M | $511M | $508M | $397M | $387M | $334M | $329M | $322M | $322M | $321M | $319M | $318M | $318M | $315M | |
| Retained Earnings | $-361M | $-343M | $-330M | $-321M | $-310M | $-297M | $-287M | $-276M | $-262M | $-250M | $-239M | $-231M | $-224M | $-216M | $-210M | $-205M | |
| AOCI | $-425.0K | $-190.0K | $148.0K | $30.0K | $24.0K | $73.0K | $61.0K | $139.0K | $-84.0K | $-67.0K | $-29.0K | $-217.0K | $-248.0K | $-88.0K | $-122.0K | $-263.0K | |
| Stockholders' Equity | $322M | $172M | $183M | $190M | $198M | $99M | $100M | $59M | $66M | $72M | $83M | $90M | $95M | $102M | $107M | $110M | |
| Liabilities + Equity | $331M | $180M | $193M | $199M | $208M | $107M | $111M | $69M | $74M | $79M | $89M | $96M | $101M | $116M | $123M | $128M | |
| Shares Outstanding | 142,420,883 | 128,411,048 | 128,306,056 | 128,215,113 | 121,775,753 | 99,892,915 | 93,602,631 | 75,454,375 | 72,591,917 | 68,960,167 | 68,283,699 | 63,855,330 | 63,098,455 | 60,065,408 | 59,943,430 | 58,322,517 |
Cashflow 11
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $34.0K | $34.0K | $31.0K | $38.0K | $38.0K | $37.0K | $38.0K | $36.0K | $38.0K | $35.0K | $35.0K | $35.0K | $34.0K | $19.0K | $15.0K | $9.0K | |
| Stock-based Comp | $3M | $2M | $1M | $1M | $1M | $1M | $916.0K | $822.0K | $1M | $723.0K | $609.0K | $530.0K | $530.0K | $578.0K | $501.0K | $569.0K | |
| Other Non-cash | · | $-6M | · | · | · | $-4M | · | · | · | $-323.0K | · | · | · | $-2M | · | · | |
| Operating Cash Flow | $-17M | $-17M | $-8M | $-11M | $-10M | $-13M | $-10M | $-10M | $-9M | $-10M | $-6M | $-7M | $-10M | $-8M | $-6M | $-9M | |
| CapEx | $124.0K | $102.0K | $0 | $12.0K | · | · | $7.0K | $0 | · | · | $22.0K | $18.0K | $40.0K | $57.0K | $116.0K | · | |
| Investing Cash Flow | $-112M | $17M | $-31M | $-51M | $-3M | $-10M | $-24M | $8M | $3M | $-8M | $13M | $18M | $20M | $9M | $-48M | $-5M | |
| Net Debt Issued | · | · | · | · | · | · | · | · | · | · | · | · | · | $-2M | · | · | |
| Financing Cash Flow | $164M | $222.0K | $284.0K | $2M | $110M | $9M | $51M | $5M | $5M | $-28.0K | $-54.0K | $2M | $-8M | $-2M | $652.0K | $55M | |
| Net Change in Cash | $35M | $498.0K | $-38M | $-60M | $98M | $-15M | $18M | $3M | $-848.0K | $-19M | $6M | $12M | $2M | $-938.0K | $-54M | $42M | |
| Free Cash Flow | · | $-17M | · | · | · | · | · | · | · | · | · | · | · | $-8M | · | · | |
| Levered FCF | · | · | · | · | · | · | · | · | · | · | · | · | · | $-8M | · | · |
Rentabilität 3
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROA | -6.6% | -9.2% | · | -8.8% | -8.7% | -11.1% | · | -16.1% | -14.1% | -11.2% | · | -6.9% | -7.8% | -8.7% | · | -10.3% | |
| ROE | -6.9% | -9.7% | · | -9.5% | -9.3% | -12.0% | · | -17.8% | -15.3% | -12.5% | · | -7.7% | -9.2% | -11.4% | · | -13.6% | |
| ROIC | -6.4% | -8.6% | · | -7.3% | -6.9% | -11.5% | · | -23.8% | -20.1% | -16.4% | · | -10.1% | -8.8% | -7.4% | · | -7.6% |
Liquidität & Solvenz 3
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 37.3 | 24.8 | · | 21.9 | 22.4 | 15.4 | · | 7.4 | 10.7 | 14.6 | · | 18.2 | 21.1 | 8.7 | · | 8.7 | |
| Quick Ratio | 36.5 | 24.1 | · | 21.6 | 22.1 | 15.0 | · | 7.2 | 10.3 | 13.8 | · | 17.2 | 20.0 | 8.4 | · | 8.6 | |
| Interest Coverage | · | · | · | · | · | · | · | · | -13289.0 | -11906.0 | · | -3015.0 | -54.8 | -32.7 | · | -28.8 |
Bewertung (TTM) 8
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income TTM | $-55M | $-48M | · | $-48M | $-48M | $-47M | · | $-44M | $-38M | $-32M | · | $-30M | $-30M | $-30M | · | $-31M | |
| Market Cap | $2.66B | $1.53B | · | $1.17B | $666M | $628M | · | $252M | $216M | $238M | · | $139M | $151M | $111M | · | $90M | |
| P/E | -50.4 | -34.1 | · | -23.5 | -12.7 | -14.0 | · | -7.6 | -7.8 | -10.8 | · | -6.6 | -6.1 | -3.3 | · | -1.8 | |
| P/B | 8.3 | 8.9 | · | 6.2 | 3.4 | 6.3 | · | 4.3 | 3.3 | 3.3 | · | 1.6 | 1.6 | 1.1 | · | 0.8 | |
| P / Tangible Book | 8.3 | 8.9 | · | 6.2 | 3.4 | 6.3 | · | 4.3 | 3.3 | 3.3 | · | 1.6 | 1.6 | 1.1 | · | 0.8 | |
| P / Cash Flow | · | -91.8 | · | · | · | -46.6 | · | · | · | -22.7 | · | · | · | -13.6 | · | · | |
| P / FCF | · | -91.2 | · | · | · | · | · | · | · | · | · | · | · | -13.5 | · | · | |
| Earnings Yield | -2.0% | -2.9% | · | -4.3% | -7.9% | -7.1% | · | -13.2% | -12.8% | -9.3% | · | -15.1% | -16.3% | -30.3% | · | -54.5% |
Finanzberichte Gewinn- und Verlustrechnung, Bilanz, Cashflow — jährlich, letzte 5 Jahre
Gewinn- und Verlustrechnung
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Nettoergebnis | $-43M | $-48M | $-29M | $-29M | $-34M |
| Verwässerte EPS | $-0.32 | $-0.47 | $-0.29 | $-0.45 | $-1.49 |
Bilanz
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Liquiditätsgrad | 19.7 | 10.4 | 15.0 | 9.2 | 3.0 |
| Quick Ratio | 19.3 | 10.2 | 14.2 | 9.0 | 2.9 |
Cashflow
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Freier Cashflow | $-42M | $-38M | $-32M | $-28M | — |
Meine Kennzahlen Ihre persönliche Watchlist — ausgewählte Zeilen aus den vollständigen Fundamentaldaten
📊
Wählen Sie die Kennzahlen, die für Sie wichtig sind — klicken Sie auf das ➕ neben jeder Zeile in den vollständigen Fundamentaldaten oben.
Ihre Auswahl wird gespeichert und begleitet Sie über alle Ticker hinweg.
Institutionelle Eigentümer (13F) 229 Einreicher · $2.5B gesamt · Stand 30. Juni 2026
Institutionen, die diese Aktie in ihrer vierteljährlichen SEC-Formular 13F melden. Nur Long-Positionen; ein einzelner Einreicher kann für separate Optionsscheine zweimal erscheinen. Große gegenläufige Put/Call-Positionen spiegeln typischerweise Market-Making oder abgesicherte Bestände wider, nicht die gerichtete Überzeugung.
Institutionelle Aktivität — Q2 2026 vs. Vorquartal
| Neue Positionen | Geschlossene Positionen | Erhöht | Abgenommen | Nettoveränderung der Aktien |
|---|---|---|---|---|
| 49 (+13 vs. Vorquartal) | 18 (-6 vs. Vorquartal) | 77 (+12 vs. Vorquartal) | 61 (-3 vs. Vorquartal) | +17.6M |
Verglichen mit Q1 2026. SEC-Formular 13F-Einreichungen sind innerhalb von 45 Tagen nach Quartalsende fällig, zuzüglich einer kurzen Pufferzeit für verspätete Einreicher — Quartale, die noch in diesem Fenster liegen, werden zugunsten des letzten vollständig berichteten Paares übersprungen.
| Institution | Wert | Aktien | % der verfolgten 13F | Typ |
|---|---|---|---|---|
| NEA Management Company, LLC | $246.594.552 | 13.222.228 | 10,04% | Aktien |
| FMR LLC | $199.426.054 | 10.693.086 | 8,12% | Aktien |
| Frazier Life Sciences Management, L.P. | $185.370.687 | 9.939.447 | 7,54% | Aktien |
| VANGUARD CAPITAL MANAGEMENT LLC | $103.147.089 | 5.530.675 | 4,20% | Aktien |
| Vivo Capital, LLC | $95.015.558 | 5.094.668 | 3,87% | Aktien |
| Woodline Partners LP | $76.116.860 | 4.081.333 | 3,10% | Aktien |
| WELLINGTON MANAGEMENT GROUP LLP | $71.755.577 | 3.847.484 | 2,92% | Aktien |
| VANGUARD GROUP INC | $70.127.888 | 5.601.269 | 2,85% | Aktien |
| Vestal Point Capital, LP | $57.815.000 | 3.100.000 | 2,35% | Aktien |
| MPM BIOIMPACT LLC | $57.322.211 | 3.073.577 | 2,33% | Aktien |
| FRONTIER CAPITAL MANAGEMENT CO LLC | $57.269.301 | 3.070.740 | 2,33% | Aktien |
| STATE STREET CORP | $56.459.425 | 3.027.315 | 2,30% | Aktien |
| MARSHALL WACE, LLP | $49.872.655 | 2.674.137 | 2,03% | Aktien |
| EVENTIDE ASSET MANAGEMENT, LLC | $49.609.000 | 2.660.000 | 2,02% | Aktien |
| GEODE CAPITAL MANAGEMENT, LLC | $46.749.639 | 2.506.090 | 1,90% | Aktien |
| Rubric Capital Management LP | $46.709.167 | 2.504.513 | 1,90% | Aktien |
| Artia Global Partners LP | $41.232.390 | 2.210.852 | 1,68% | Aktien |
| ACORN CAPITAL ADVISORS, LLC | $40.001.341 | 2.144.844 | 1,63% | Aktien |
| First Light Asset Management, LLC | $39.113.060 | 2.097.215 | 1,59% | Aktien |
| Pictet Asset Management Holding SA | $37.557.109 | 2.013.786 | 1,53% | Aktien |
| Logos Global Management LP | $35.062.000 | 1.880.000 | 1,43% | Aktien |
| Affinity Asset Advisors, LLC | $33.573.208 | 1.800.172 | 1,37% | Aktien |
| EMERALD ADVISERS, LLC | $33.525.445 | 1.797.611 | 1,36% | Aktien |
| Siren, L.L.C. | $33.325.070 | 1.786.867 | 1,36% | Aktien |
| Pivotal bioVenture Partners Investment Advisor LLC | $32.500.833 | 1.742.672 | 1,32% | Aktien |
| VIKING GLOBAL INVESTORS LP | $28.807.611 | 1.544.644 | 1,17% | Aktien |
| Assenagon Asset Management S.A. | $28.447.106 | 1.525.314 | 1,16% | Aktien |
| ALLIANCEBERNSTEIN L.P. | $28.100.554 | 2.355.453 | 1,14% | Aktien |
| BANK OF AMERICA CORP /DE/ | $26.936.643 | 1.444.324 | 1,10% | Aktien |
| ORBIMED ADVISORS LLC | $26.674.964 | 1.430.293 | 1,09% | Aktien |
| Jones Hill Capital LP | $24.976.304 | 1.339.212 | 1,02% | Aktien |
| NAN FUNG TRINITY (HK) LTD | $22.634.013 | 1.213.620 | 0,92% | Aktien |
| EMERALD MUTUAL FUND ADVISERS TRUST | $22.584.497 | 1.210.965 | 0,92% | Aktien |
| Soleus Capital Management, L.P. | $21.999.876 | 1.179.618 | 0,90% | Aktien |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $21.948.663 | 1.176.872 | 0,89% | Aktien |
| BARCLAYS PLC | $21.199.213 | 1.136.687 | 0,86% | Aktien |
| GOLDMAN SACHS GROUP INC | $19.825.528 | 1.063.031 | 0,81% | Aktien |
| Saturn V Capital Management LP | $19.620.602 | 1.052.043 | 0,80% | Aktien |
| FLPUTNAM INVESTMENT MANAGEMENT CO | $19.359.763 | 1.038.057 | 0,79% | Aktien |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $18.138.990 | 972.600 | 0,74% | Kaufoption |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $18.004.747 | 965.402 | 0,73% | Aktien |
| Candriam S.C.A. | $18.002.647 | 966.219 | 0,73% | Aktien |
| RAYMOND JAMES FINANCIAL INC | $17.533.126 | 940.114 | 0,71% | Aktien |
| Balyasny Asset Management L.P. | $15.760.873 | 845.087 | 0,64% | Aktien |
| VANGUARD FIDUCIARY TRUST CO | $15.685.750 | 841.059 | 0,64% | Aktien |
| Burkehill Global Management, LP | $13.521.250 | 725.000 | 0,55% | Aktien |
| SILVERARC CAPITAL MANAGEMENT, LLC | $12.646.472 | 678.095 | 0,51% | Aktien |
| AMERIPRISE FINANCIAL INC | $11.572.904 | 620.531 | 0,47% | Aktien |
| SUPERSTRING CAPITAL MANAGEMENT LP | $9.776.778 | 524.224 | 0,40% | Aktien |
| SPHERA FUNDS MANAGEMENT LTD. | $9.306.891 | 499.029 | 0,38% | Aktien |
| PEREGRINE CAPITAL MANAGEMENT LLC | $8.286.382 | 444.310 | 0,34% | Aktien |
| KVP Capital Advisors, LP | $7.721.100 | 414.000 | 0,31% | Aktien |
| Ensign Peak Advisors, Inc | $7.388.626 | 396.173 | 0,30% | Aktien |
| Octagon Capital Advisors LP | $5.874.750 | 315.000 | 0,24% | Aktien |
| Opaleye Management Inc. | $5.781.500 | 310.000 | 0,24% | Aktien |
| BlackRock, Inc. | $5.355.515 | 287.159 | 0,22% | Aktien |
| Informed Momentum Co LLC | $4.935.368 | 264.631 | 0,20% | Aktien |
| FIFTH THIRD BANCORP | $4.861.011 | 260.644 | 0,20% | Aktien |
| Rock Springs Capital Management LP | $4.849.000 | 260.000 | 0,20% | Aktien |
| Trexquant Investment LP | $4.523.315 | 242.537 | 0,18% | Aktien |
| Walleye Capital LLC | $4.513.058 | 241.987 | 0,18% | Aktien |
| F/m Investments LLC | $4.367.979 | 234.208 | 0,18% | Aktien |
| JANE STREET GROUP, LLC | $3.761.705 | 201.700 | 0,15% | Kaufoption |
| Integral Health Asset Management, LLC | $3.730.000 | 200.000 | 0,15% | Aktien |
| Swiss National Bank | $3.586.395 | 192.300 | 0,15% | Aktien |
| PANAGORA ASSET MANAGEMENT INC | $3.398.683 | 182.235 | 0,14% | Aktien |
| Nuveen, LLC | $3.292.602 | 176.547 | 0,13% | Aktien |
| SEVEN GRAND MANAGERS, LLC | $2.797.500 | 150.000 | 0,11% | Aktien |
| RHUMBLINE ADVISERS | $2.470.423 | 132.463 | 0,10% | Aktien |
| TRUST CO OF TOLEDO NA /OH/ | $2.312.637 | 124.002 | 0,09% | Aktien |
| D. E. Shaw & Co., Inc. | $2.286.415 | 122.596 | 0,09% | Aktien |
| CITADEL ADVISORS LLC | $2.170.860 | 116.400 | 0,09% | Kaufoption |
| Harvest Investment Services, LLC | $2.146.690 | 115.104 | 0,09% | Aktien |
| WINTON GROUP Ltd | $1.992.790 | 106.852 | 0,08% | Aktien |
| Bank of New York Mellon Corp | $1.959.854 | 105.086 | 0,08% | Aktien |
| Qube Research & Technologies Ltd | $1.906.515 | 102.226 | 0,08% | Aktien |
| LMR Partners LLP | $1.865.000 | 100.000 | 0,08% | Aktien |
| OPPENHEIMER & CO INC | $1.860.729 | 99.771 | 0,08% | Aktien |
| SIMPLEX TRADING, LLC | $1.819.438 | 97.557 | 0,07% | Aktien |
| WEXFORD CAPITAL LP | $1.692.525 | 90.752 | 0,07% | Aktien |
| Erste Asset Management GmbH | $1.676.700 | 90.000 | 0,07% | Aktien |
| STATE OF WISCONSIN INVESTMENT BOARD | $1.543.343 | 82.753 | 0,06% | Aktien |
| Campbell & CO Investment Adviser LLC | $1.526.950 | 81.874 | 0,06% | Aktien |
| J. Goldman & Co LP | $1.510.613 | 80.998 | 0,06% | Aktien |
| PFS Partners, LLC | $1.473.350 | 79.000 | 0,06% | Aktien |
| Schonfeld Strategic Advisors LLC | $1.416.838 | 75.970 | 0,06% | Aktien |
| Checkpoint Capital L.P. | $1.398.750 | 75.000 | 0,06% | Aktien |
| TUDOR INVESTMENT CORP ET AL | $1.379.690 | 73.978 | 0,06% | Aktien |
| VANGUARD ASSET MANAGEMENT, Ltd | $1.348.320 | 72.296 | 0,05% | Aktien |
| CITIGROUP INC | $1.329.540 | 71.289 | 0,05% | Aktien |
| FRED ALGER MANAGEMENT, LLC | $1.240.039 | 66.490 | 0,05% | Aktien |
| SECTORAL ASSET MANAGEMENT INC | $1.223.365 | 65.596 | 0,05% | Aktien |
| Vanguard Global Advisers, LLC | $1.198.785 | 64.278 | 0,05% | Aktien |
| Steward Partners Investment Advisory, LLC | $1.186.140 | 63.600 | 0,05% | Aktien |
| LPL Financial LLC | $1.183.324 | 63.449 | 0,05% | Aktien |
| KENNEDY CAPITAL MANAGEMENT LLC | $1.176.964 | 63.108 | 0,05% | Aktien |
| MetLife Investment Management, LLC | $1.165.494 | 62.493 | 0,05% | Aktien |
| XTX Topco Ltd | $1.154.360 | 61.896 | 0,05% | Aktien |
| WealthTrust Axiom LLC | $1.146.975 | 61.500 | 0,05% | Aktien |
| MAI Capital Management | $1.046.825 | 56.130 | 0,04% | Aktien |
Unternehmensinsider 37 Insider · 13 Führungskräfte · 9 Direktoren
| Insider | Rolle | Letzte Aktivität | Gehaltene Aktien | Käufe 12m | Verkäufe 12m | Netto 12m |
|---|---|---|---|---|---|---|
| Jennifer L Good | President & CEO | 19. Februar 2026 A | 213.313 | 0 | 0 | $0 |
| David C Hastings | Chief Financial Officer | 8. Januar 2026 A | — | 0 | 0 | $0 |
| Lisa Delfini | Chief Financial Officer | 31. Mai 2025 A | 64.660 | 0 | 0 | $0 |
| Christopher Seiter | Chief Financial Officer | 17. Februar 2021 A | — | 0 | 0 | $0 |
| Farrell Simon | Chief Commercial Officer | 19. Februar 2026 A | 76.900 | 0 | 0 | $0 |
| Christopher Galletta | Controller and Principal Accounting Officer | 19. Februar 2026 A | 26.095 | 0 | 0 | $0 |
| James V Cassella | Chief Development Officer | 19. Februar 2026 A | — | 0 | 0 | $0 |
| Thomas Sciascia | Chief Scientific Officer | 19. Februar 2026 A | 221.373 | 0 | 0 | $0 |
| David J Clark | Chief Medical Officer | 15. Februar 2024 A | — | 0 | 0 | $0 |
| William P Forbes | Chief Development Officer | 29. Juni 2022 A | — | 0 | 0 | $0 |
| Frank P Muscolo | Controller | 17. Februar 2021 A | — | 0 | 0 | $0 |
| Helena Brett-Smith | Chief Development Officer | 13. Februar 2020 A | — | 0 | 0 | $0 |
| Yann Mazabraud | Chief Commercial Officer and Head of International | 13. Februar 2020 A | — | 0 | 0 | $0 |
| Michael Thomas Heffernan | Direktor | 3. Juni 2026 A | 6.351 | 0 | 0 | $0 |
| David P Meeker | Direktor | 3. Juni 2026 A | 352.489 | 0 | 0 | $0 |
| Edward T. Mathers | Direktor | 3. Juni 2026 A | 948.948 | 0 | 0 | $0 |
| Dominick Colangelo | Direktor | 3. Juni 2026 A | — | 0 | 0 | $0 |
| Anne Vanlent | Direktor | 3. Juni 2026 A | 25.983 | 0 | 0 | $0 |
| Mette Kirstine Agger | Direktor | 9. Mai 2019 C | 1.151.544 | 0 | 0 | $0 |
| Anna Guyer Mitsak | Direktor | 7. Mai 2019 A | — | 0 | 0 | $0 |
| Eran Nadav | Direktor | 7. Mai 2019 A | — | 0 | 0 | $0 |
| Mohamad Makhzoumi | 10%-Eigentümer | 11. April 2022 P | 948.948 | 0 | 0 | $0 |
| Ali Behbahani | 10%-Eigentümer | 11. April 2022 P | 948.948 | 0 | 0 | $0 |
| Anthony A. Florence, Jr. | 10%-Eigentümer | 11. April 2022 P | 948.948 | 0 | 0 | $0 |
| Peter W. Sonsini | 10%-Eigentümer | 11. April 2022 P | 948.948 | 0 | 0 | $0 |
| Paul Walker | 10%-Eigentümer | 11. April 2022 P | 948.948 | 0 | 0 | $0 |
| Forest Baskett | 10%-Eigentümer | 11. April 2022 P | 10.421.428 | 0 | 0 | $0 |
| Scott D. Sandell | 10%-Eigentümer | 11. April 2022 P | 948.948 | 0 | 0 | $0 |
| Joshua Makower | 10%-Eigentümer | 3. April 2020 X | 5.937.998 | 0 | 0 | $0 |
| Debra A Drake | 10%-Eigentümer | 9. Mai 2019 C | 10.399 | 0 | 0 | $0 |
| Richard King Mellon Foundation | 10%-Eigentümer | 9. Mai 2019 C | 347.157 | 0 | 0 | $0 |
| Lundbeckfond Invest A/S | 10%-Eigentümer | 9. Mai 2019 C | 1.151.544 | 0 | 0 | $0 |
| Peter F Drake | 10%-Eigentümer | 9. Mai 2019 C | 62.540 | 0 | 0 | $0 |
| William J Oshea | 10%-Eigentümer | 9. Mai 2019 C | 114.080 | 0 | 0 | $0 |
| David M Mott | 10%-Eigentümer | 9. Mai 2019 C | 4.438.562 | 0 | 0 | $0 |
| Peter J Barris | 10%-Eigentümer | 9. Mai 2019 C | 4.438.562 | 0 | 0 | $0 |
| Carmen Chang | — | 11. April 2022 P | 948.948 | 0 | 0 | $0 |
Insider aus SEC-Einreichungen Form 3/4/5; Netto = nur P/S aus offenen Märkten
Aktivisten & 5%+-Eigentümer 2 Beteiligungen
Investoren mit SEC Schedule 13D — wirtschaftliches Eigentum über 5% mit der Absicht, Einfluss auf den Emittenten zu nehmen (aktivistische Beteiligungen, Board-Kampagnen, M&A). Jede Zeile zeigt den zuletzt bekannten Stand der Position dieses Melders.
| Anmelder | Eingereicht | Beteiligung | Status | Zweck | Einreichung |
|---|---|---|---|---|---|
| New Enterprise Associates 16, L.P., NEA Partners 16, L.P., NEA 16 GP, LLC, NEA 18 Venture Growth Equity, L.P., NEA Partners 18 VGE, L.P., NEA 18 VGE GP, LLC, Forest Baskett, Ali Behbahani, Carmen Chang, Anthony A. Florence, Jr., Mohamad H. Makhzoumi, Scott D. Sandell, Paul Walker ×10 Einreichungen | 7. Mai 2026 | 10,50% | Änderung | Passive Anlage | SEC |
| Omega Fund V, L.P., Omega Fund V GP, L.P., Omega Fund V GP Manager, Ltd., Richard J. Lim, Claudio Nessi, Anne-Mari Paster, Otello Stampacchia | 20. Mai 2019 | — | Erste Einreichung | Vorstandskampagne | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
ETF-Besitz Gehalten von 34 ETFs
Gewichtung spiegelt nur direkte Aktienbestände (N-PORT) wider; gehebelte oder derivatbasierte Fonds können zusätzliche Swap-Exposure halten, die hier nicht angezeigt wird.
| Fonds | Gewicht | Anteile | Stand | Quelle |
|---|---|---|---|---|
| LFSC · RBB Fund, Inc. | 3,12% | 231.602 NS | 31. Mai 2026 | N-PORT |
| PILL · Direxion Shares ETF Trust | 1,54% | 14.451 NS | 30. April 2026 | N-PORT |
| PTH · Invesco Exchange-Traded Fund Trust | 1,14% | 152.167 SH | 8. August 2026 | Täglich |
| DWAS · Invesco Exchange-Traded Fund Trust … | 0,70% | 169.047 SH | 8. August 2026 | Täglich |
| IHE · iShares Trust | 0,48% | 421.149 SH | 8. August 2026 | Täglich |
| IBBQ · Invesco Exchange-Traded Fund Trust … | 0,18% | 7.729 SH | 8. August 2026 | Täglich |
| VFMO · VANGUARD WELLINGTON FUND | 0,14% | 148.479 SH | 8. August 2026 | Täglich |
| IBB · iShares Trust | 0,13% | 680.175 SH | 8. August 2026 | Täglich |
| IWO · iShares Trust | 0,12% | 965.282 SH | 8. August 2026 | Täglich |
| VTWG · VANGUARD SCOTTSDALE FUNDS | 0,12% | 114.901 SH | 8. August 2026 | Täglich |
| BIB · ProShares Trust | 0,09% | 4.742 NS | 31. Mai 2026 | N-PORT |
| ISCG · iShares Trust | 0,07% | 37.042 SH | 8. August 2026 | Täglich |
| ESML · iShares Trust | 0,06% | 100.384 SH | 8. August 2026 | Täglich |
| IWM · iShares Trust | 0,06% | 2.708.707 SH | 8. August 2026 | Täglich |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,06% | 616.796 SH | 8. August 2026 | Täglich |
| RSSL · Global X Funds | 0,04% | 41.397 NS | 30. April 2026 | N-PORT |
| SCHA · SCHWAB STRATEGIC TRUST | 0,03% | 554.292 NS | 31. Mai 2026 | N-PORT |
| ISCB · iShares Trust | 0,03% | 5.335 SH | 8. August 2026 | Täglich |
| ITWO · ProShares Trust | 0,03% | 4.499 NS | 31. Mai 2026 | N-PORT |
| VHT · VANGUARD WORLD FUND | 0,03% | 287.822 SH | 8. August 2026 | Täglich |
| GSSC · Goldman Sachs ETF Trust | 0,03% | 18.627 NS | 31. Mai 2026 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | 0,02% | 1.352.952 SH | 8. August 2026 | Täglich |
| UWM · ProShares Trust | 0,02% | 3.519 NS | 31. Mai 2026 | N-PORT |
| FHLC · FIDELITY COVINGTON TRUST | 0,02% | 40.477 NS | 30. April 2026 | N-PORT |
| URTY · ProShares Trust | 0,01% | 3.558 NS | 31. Mai 2026 | N-PORT |
| WSML · iShares Trust | 0,01% | 5.160 SH | 8. August 2026 | Täglich |
| MSSM · MORGAN STANLEY PATHWAY FUNDS | 0,01% | 3.851 NS | 31. Mai 2026 | N-PORT |
| HDG · ProShares Trust | 0,01% | 89 NS | 31. Mai 2026 | N-PORT |
| ONEQ · Fidelity Commonwealth Trust | 0,01% | 41.948 NS | 31. Mai 2026 | N-PORT |
| ITOT · iShares Trust | 0,00% | 152.449 SH | 8. August 2026 | Täglich |
| IWV · iShares Trust | 0,00% | 24.494 SH | 8. August 2026 | Täglich |
| SCHB · SCHWAB STRATEGIC TRUST | 0,00% | 59.480 NS | 31. Mai 2026 | N-PORT |
| VTI · VANGUARD INDEX FUNDS | 0,00% | 4.048.595 SH | 8. August 2026 | Täglich |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,00% | 8.874 SH | 8. August 2026 | Täglich |